Molecular Imaging

SNMMI: For PET drugs, sterility assurance level bests sterility testing

By Liz Carey

Sterility testing is limited when it comes to detecting microbial contamination in PET drugs.

June 25, 2025

SNMMI: Jacene named president-elect

The SNMMI has named Heather Jacene, MD, as its president-elect.

June 24, 2025

SNMMI names Ulaner as vice president-elect

By AuntMinnie.com staff writers

Gary Ulaner, MD, PhD, has been named vice president-elect of the Society of Nuclear Medicine and Molecular Imaging (SNMMI).

June 24, 2025

Urbain takes helm as SNMMI president

By AuntMinnie.com staff writers

Jean-Luc Urbain, MD, PhD, has been named president of the Society of Nuclear Medicine and Molecular Imaging (SNMMI).

June 24, 2025

FDA approves expanded uses for GE Healthcare’s Vizamyl

By AuntMinnie.com staff writers

The U.S. FDA has approved expanded indications for GE HealthCare’s Vizamyl PET imaging agent for beta-amyloid detection.

June 24, 2025

SNMMI: Botox may prevent debilitating dry mouth for some mCRPC patients

By Liz Carey

Research presented at the meeting addressed salivary gland toxicity associated with uptake of PSMA-targeted radioligand therapy.

June 24, 2025

Nuclidium presents phase I results for PSMA tracer at SNMMI

By AuntMinnie.com staff writers

Nuclidium presented positive data from the phase I clinical trial of its new copper-61 PET imaging agent for prostate cancer.

June 24, 2025

SNMMI: New PET imaging technique detects mycobacteria lung infections

By Kate Madden Yee

These infections are some of the most difficult-to-diagnose in patients with chronic lung diseases.

June 24, 2025

SNMMI: PET tracer images brain inflammation

By Amerigo Allegretto

A PET radiotracer can produce high-quality, real-time images of brain inflammation, which may help with diagnosing and treating neurological diseases.

June 24, 2025

Video from SNMMI: Cathy Cutler on the state of the field in 2025

By Will Morton

Current SNMMI President Cathy Cutler, PhD, discusses the state of the field in 2025 and the challenges ahead.

June 24, 2025

SNMMI: PET approach finds more inflammation in PAOS patients

By Amerigo Allegretto

A novel PET imaging approach could help in better managing patients with progressive apraxia of speech (PAOS).

June 24, 2025

SNMMI: New molecular imaging agent shows promise for detecting HCC

By Kate Madden Yee

A new molecular imaging agent has shown high sensitivity and specificity in detecting hepatocellular carcinoma (HCC).

June 23, 2025

Page 1 of 609

Next Page